Luteolytic Agents

Name
Luteolytic Agents
Accession Number
DBCAT001156
Description

Chemical compounds causing LUTEOLYSIS or degeneration.

Drugs
DrugDrug Description
CloprostenolNot Annotated
MifepristoneA cortisol receptor blocker used to treat Cushing's syndrome, and to terminate pregnancies up to 70 days gestation.
TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
FluprostenolNot Annotated
Drugs & Drug Targets
DrugTargetType
MifepristoneProgesterone receptortarget
MifepristoneGlucocorticoid receptortarget
MifepristoneCytochrome P450 3A4enzyme
MifepristoneCytochrome P450 3A5enzyme
MifepristoneP-glycoprotein 1transporter
MifepristoneMultidrug resistance-associated protein 1transporter
MifepristoneCytochrome P450 2D6enzyme
MifepristoneProstate-specific antigentarget
MifepristoneNuclear receptor subfamily 1 group I member 2target
MifepristoneBile salt export pumptransporter
MifepristoneCytochrome P450 2C8enzyme
MifepristoneCytochrome P450 2C9enzyme
MifepristoneSolute carrier organic anion transporter family member 1B1transporter
MifepristoneSolute carrier organic anion transporter family member 1B3transporter
TriptorelinGonadotropin-releasing hormone receptortarget